Clinical Trial Update: OLP-1002 is Being Studied in the Treatment of Pain. [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 clinical trial update for OLP-1002 studying its use in treating pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• OLP-1002 (OLP-1002)

Snippet

Sponsor: OliPass Corporation | Conditions: Pain | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-08-26